These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26363188)

  • 61. Design, Synthesis, Evaluation and Structure of Allenic 1α,25-Dihydroxyvitamin D
    Fraga R; Len K; Lutzing R; Laverny G; Loureiro J; Maestro MA; Rochel N; Rodriguez-Borges E; Mouriño A
    Chemistry; 2021 Sep; 27(53):13384-13389. PubMed ID: 34224173
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stereoselective convergent synthesis of 24-substituted metabolites and analogues of vitamin D.
    Cornella I; Suárez RM; Mouriño A; Sestelo JP; Sarandeses LA
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):19-23. PubMed ID: 15225740
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synthesis and biological activity of previtamin D(3) analogues with A-ring modifications.
    Sánchez-Abella L; Fernández S; Verstuyf A; Verlinden L; Gotor V; Ferrero M
    Bioorg Med Chem; 2008 Dec; 16(24):10244-50. PubMed ID: 19006670
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist.
    Kato Y; Nakano Y; Sano H; Tanatani A; Kobayashi H; Shimazawa R; Koshino H; Hashimoto Y; Nagasawa K
    Bioorg Med Chem Lett; 2004 May; 14(10):2579-83. PubMed ID: 15109656
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synthesis of Diastereomers of 1,3-cis-25-Dihydroxy-19-norvitamin D3.
    Usuda K; Biswas T; Yamaguchi T; Akagi Y; Yasui K; Uesugi M; Shimizu I; Hosokawa S; Nagasawa K
    Chem Pharm Bull (Tokyo); 2016; 64(8):1190-5. PubMed ID: 27477659
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Versatile synthesis and biological evaluation of 1,3-diamino-substituted 1alpha,25-dihydroxyvitamin D3 analogues.
    Oves D; Fernández S; Ferrero M; Bouillon R; Verstuyf A; Gotor V
    Bioorg Med Chem; 2006 Feb; 14(4):928-37. PubMed ID: 16213141
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis and biological activities of new 1alpha,25-dihydroxy-19-norvitamin D3 analogs with modifications in both the A-ring and the side chain.
    Shimizu M; Miyamoto Y; Kobayashi E; Shimazaki M; Yamamoto K; Reischl W; Yamada S
    Bioorg Med Chem; 2006 Jun; 14(12):4277-94. PubMed ID: 16503143
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Design and efficient synthesis of new stable 1alpha,25-dihydroxy-19-norvitamin D3 analogues containing amide bond.
    Suhara Y; Kittaka A; Ono K; Kurihara M; Fujishima T; Yoshida A; Takayama H
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3533-6. PubMed ID: 12443770
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Application of the solid-phase Julia-Lythgoe olefination in vitamin D side-chain construction.
    D'herde JN; De Clercq PJ
    Molecules; 2006 Aug; 11(8):655-60. PubMed ID: 17971738
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel side chain analogs of 1alpha,25-dihydroxyvitamin D(3): design and synthesis of the 21,24-methano derivatives.
    Calverley MJ
    Steroids; 2001; 66(3-5):249-55. PubMed ID: 11179732
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D3 analogues with aromatic side chains attached at C-17.
    Liu C; Zhao GD; Mao X; Suenaga T; Fujishima T; Zhang CM; Liu ZP
    Eur J Med Chem; 2014 Oct; 85():569-75. PubMed ID: 25127149
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Novel A-ring homodimeric C-3-carbamate analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation.
    Oves D; Fernández S; Verlinden L; Bouillon R; Verstuyf A; Ferrero M; Gotor V
    Bioorg Med Chem; 2006 Nov; 14(22):7512-9. PubMed ID: 16879968
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
    Peleg S; Petersen KS; Suh BC; Dolan P; Agoston ES; Kensler TW; Posner GH
    J Med Chem; 2006 Dec; 49(25):7513-7. PubMed ID: 17149880
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Seco-B-Ring Steroidal Dienynes with Aromatic D Ring: Design, Synthesis and Biological Evaluation.
    Szybinski M; Brzeminski P; Fabisiak A; Berkowska K; Marcinkowska E; Sicinski RR
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039779
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: spiro[5.5]undecane CF-ring analogues.
    Schepens W; Van Haver DV; Vandewalle M; De Clercq PJ; Bouillon R; Verstuyf A
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3889-92. PubMed ID: 15225691
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Methyl-introduced A-ring analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological evaluation.
    Fujishima T; Tsutsumi R; Negishi Y; Fujii S; Takayama H; Kittaka A; Kurihara M
    Anticancer Res; 2006; 26(4A):2633-6. PubMed ID: 16886673
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis and preliminary biological evaluation of new antiproliferative aromatic analogues of 1α,25-dihydroxyvitamin D3.
    Thomas E; Brion JD; Peyrat JF
    Eur J Med Chem; 2014 Oct; 86():381-93. PubMed ID: 25180926
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Difluoromethyl analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: Design, synthesis, and preliminary biological evaluation.
    Posner GH; Suh BC; Petersen KS; Dolan P; Agoston ES; Kensler TW; Koh JT; Peleg S
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):213-21. PubMed ID: 17218093
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Highly potent vitamin D receptor antagonists: design, synthesis, and biological evaluation.
    Saito N; Kittaka A
    Chembiochem; 2006 Oct; 7(10):1479-90. PubMed ID: 16871612
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis of all possible A-ring diastereomers at the 1- and 3-positions of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71) using C2-symmetrical epoxide as a common starting material.
    Kubodera N; Hatakeyama S
    Anticancer Res; 2009 Sep; 29(9):3571-8. PubMed ID: 19667150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.